Arne Materna

Mar 08, 2018

CosmosID announced today that it appointed Arne Materna as its VP of product. Materna previously worked at Qiagen, where he directed the product management organization responsible for a high-growth segment of Qiagen's portfolio of bioinformatics products. Prior to Qiage, Materna held managment and senior roles at CLC bio, Pacific Biosciences, and MIT.

Breaking News

Gastric Cancer Chemotherapy Response, Prognoses Predicted With Blood-Based Immune Proteomics
International Commission to Expand Molecular Testing Access for Cancer Patients
NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test
SomaLogic Expands Into Middle East With Proteomics Supply Deal for Group 42 Healthcare
Arima Genomics to Offer NGS-Based Gene Fusion Test Through Protean BioDiagnostics CLIA Lab

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.